All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 22, 2022
Home » Topics » Science

Science
Science RSS Feed RSS

Nanoparticles make microfractures visible on color CT

Nov. 25, 2019
By Annette Boyle
No Comments
Hafnium nanoparticles that home onto microfractures in bone make the tiny cracks visible in spectral or color computed tomography (CT) imaging. Researchers at the University of Illinois at Urbana-Champaign and the University of Maryland created the nanotechnology to work in conjunction with spectral molecular imaging developed by New Zealand-based MARS Bioimaging Ltd. (MBI). The research appeared in Advanced Functional Materials.
Read More
Antibiotic susceptibility testing
Genotype and phenotype

‘PhASTer’ susceptibility testing could improve antibiotic use, trials

Nov. 25, 2019
By Anette Breindl
No Comments
One necessary step to fend off a dystopian future of medical care without antibiotics is the development of new antibiotics. Another is improved deployment of existing ones, a feat which will take, among other things, better antibiotic susceptibility testing (AST). 
Read More

Australian researchers create kidney tissue from iPS cells

Nov. 25, 2019
By Tamra Sami
No Comments
MELBOURNE, Australia – Researchers at the Murdoch Children’s Research Institute in Melbourne are pushing the boundaries on creating kidney tissue from stem cells.
Read More

Bioworld MedTech’s Cardiology Extra

Nov. 25, 2019
By Liz Hollis
No Comments
Keeping you up to date on recent developments in cardiology.
Read More
Test tube, dropper, DNA illustration

Bench Press for Nov. 22, 2019

Nov. 22, 2019
By Anette Breindl
No Comments
BioWorld looks at translational medicine.
Read More

Bioworld MedTech’s Neurology extra

Nov. 22, 2019
By Andrea Applegate and Anette Breindl
No Comments
Keeping you up to date on recent developments in neurology.
Read More

Bioworld MedTech’s Diagnostics extra

Nov. 21, 2019
By Meg Bryant and Anette Breindl
No Comments
Keeping you up to date on recent developments in diagnostics.
Read More

BioWorld MedTech's Orthopedics Extra

Nov. 20, 2019
By Holland Johnson
No Comments
Keeping you up to date on recent developments in orthopedics.
Read More
Older person holding cane

Double-duty CD4+ T cells may hold key to longevity

Nov. 19, 2019
By John Fox
No Comments
Researchers at the RIKEN Center for Integrative Medical Science (IMS) and Keio University School of Medicine (KUSM) in Japan have discovered that people ages 110 or longer, the so-called supercentenarians, have elevated blood levels of CD4+ cytotoxic T lymphocytes (CTLs).
Read More

BioWorld MedTech's Oncology Extra

Nov. 19, 2019
By Mark McCarty
No Comments
Keeping you up to date on recent developments in oncology.
Read More
Previous 1 2 … 117 118 119 120 121 122 123 124 125 … 131 132 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 20, 2022.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for May 20.
  • China U.S. deal

    Merck acquires global rights to cancer drug from Kelun in $1.4B deal

    BioWorld
    In a deal potentially worth more than $1.4 billion, Sichuan Kelun Pharmaceutical Co. Ltd. has out-licensed a large molecule drug in cancer to Merck & Co. Inc. for...
  • Illustration of cancer cells and immunotherapy treatment

    Former Genentech execs launch new immunotherapy biotech LTZ Therapeutics

    BioWorld
    After raising $17 million in seed funding, immunotherapy-focused biotech company, LTZ Therapeutics Inc., is announcing plans for the fledgling company whose...
  • US FDA rejects UCB psoriasis drug Bimzelx, citing facility inspection issues

    BioWorld
    UCB SA’s share price slumped after the U.S. FDA rejected the pharma’s filing for psoriasis drug Bimzelx (bimekizumab), citing issues with “inspection...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing